Cardiovascular disease test kit LP-PLA2

lipoproteinserumplasma

Matching Equipments: Solid Phase Fluorescence Immunoassay System Manufactured by Guangzhou KOFA Biotechnology Co.,Ltd. Intended Use:This kit is used for in vitro quantitative detection of the content of Lp-PLA2 in human serum, plasma or whole blood samples. Lipoprotein-associated phospholipase A2 is a member of the phospholipase A2 superfamily. It is synthesized and secreted by mature macrophages and lymphocytes. It is a new vascular inflammatory marker in cardiovascular and cerebrovascular diseases. The increase in Lp-PLA2 activity can promote the occurrence and development of atherosclerosis (AS). Studies have shown that Lp-PLA2 is upregulated in atherosclerosis (AS). The detection of Lp-PLA2 can reflect the instability of atherosclerotic plaques and further reflect the severity of coronary heart disease. At the same time, Lp-PLA2 is also an independent predictor of ischemic stroke. The determination of Lp-PLA2 levels can provide predictive information beyond the traditional risk factor assessment.